Biomarkers for Diagnosing Equine Asthma

Simple SummaryContent extracted from patent full text and abstract with AI.

This invention discloses the use of specific proteins—mucin-4, polymeric immunoglobulin receptor, carcinoembryonic antigen-related cell adhesion molecule 1, CD177, and vanin 1—as biomarkers for diagnosing asthma in horses (equine asthma). By analyzing airway secretions, especially mucus samples, for elevated levels of these proteins, veterinarians can detect both mild and severe forms of equine asthma more reliably and less invasively than traditional diagnostics.

Use CasesContent extracted from patent full text and abstract with AI.

• Routine veterinary screening of horses for early detection of equine asthma.
• Point-of-care diagnostic tests (such as test kits) for equine asthma using mucus samples or airway secretions.
• Monitoring disease progression or treatment efficacy in horses diagnosed with equine asthma.
• Large-scale health monitoring in horse stables, racing, or breeding facilities to detect outbreaks of respiratory issues.
• Research on respiratory diseases in horses, enabling better understanding and management of equine asthma.

BenefitsContent extracted from patent full text and abstract with AI.

• Enables minimally invasive and simple sample collection (via mucus or airway secretions), reducing stress and discomfort for the animal.
• Provides more specific and reliable diagnosis by detecting protein biomarkers that distinguish healthy horses from those with asthma.
• Can facilitate the development of rapid, user-friendly diagnostic tools suitable for veterinarians and even horse owners.
• Allows diagnosis of both mild and severe forms of equine asthma, improving early intervention and management.
• Reduces financial and time burdens compared to current diagnostic methods, making it more accessible for regular use.

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

The present invention relates to the use of a protein chosen from the group consisting of mucin-4, polymeric immunoglobulin receptor, carcinoembryonic antigen-related cell adhesion molecule 1, CD177, and vanin 1 as biomarker in an in vitro method for diagnosing equine asthma of an equine patient.